Skip to content

An open label randomized crossover study on hybrid assistive limb (HAL) therapy for Parkinson disease

An open label randomized crossover study on hybrid assistive limb (HAL) therapy for Parkinson disease - An efficacy study on hybrid assistive limb (HAL) therapy for Parkinson disease

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031376
Enrollment
20
Registered
2018-02-20
Start date
2018-02-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson disease

Interventions

In the HAL therapy group, the patients undergo walking training with HAL for 40 minutes a day, 9 times in total, and walking training without HAL for 40 minutes a day, 2 times. In the conventional reh

Sponsors

Ichinomiya Nishi Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patients meet clinically established or clinically probable cases of the clinical diagnostic criteria of Parkinson disease by Movement Disorder Society 2. Hoehn & Yahr classification is 3 or 4 3. The patients are treated with L-dopa 4. Hospitalization or outpatient visit is possible during the intervention period 5. Written consent has been obtained

Exclusion criteria

Exclusion criteria: 1. Decline in the cognitive function (MMSE 23 points or less) 2. Muscle weakness due to neuromuscular disease 3. The patients cannot walk for 2 minutes 4. Strong posture abnormality (score of '3.13 Posture' in MDS-UPDRS three points or more) 5. Wearing off time of more than 25% of awake time

Design outcomes

Primary

MeasureTime frame
Primary outcome is walking speed, number of steps, and stride.

Secondary

MeasureTime frame
Secondary outcomes were Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS), postural instability and gait difficulty score of MDS-UPDRS, Time Up and Go test, Mini Balance Evaluation Systems Test, Functional Reach test, Freezing of Gait Questionnaire, Parkinson disease Questionnaire -39.

Countries

Japan

Contacts

Public ContactMasahiro Kanai

Ichinomiya Nishi Hospital Neurology

masabilliard35@yahoo.co.jp0586-48-0077

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026